Our client, a US-based hedge fund, wanted us to construct a portfolio comprising of biotechnology and pharmaceutical companies based in the US with a market cap in the range of USD 500 Mn to 2 Bn and in clinical stage for COVID-19 Vaccine development.
Selected 100+ US-based Pharma and biotech Companies on key parameter.
Screened 30 companies based on key parameter like clinical stage, efficacy rate etc.
Conducted in-depth research on 30 companies and Selected 22 companies.
Back tested the portfolio with different weights to get optimal portfolio.
Tracked the Portfolio for a month